0001209191-14-073398.txt : 20141205 0001209191-14-073398.hdr.sgml : 20141205 20141205162557 ACCESSION NUMBER: 0001209191-14-073398 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141204 FILED AS OF DATE: 20141205 DATE AS OF CHANGE: 20141205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Connolly Thomas CENTRAL INDEX KEY: 0001453943 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 141269913 MAIL ADDRESS: STREET 1: 717 FIFTH AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-12-04 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001453943 Connolly Thomas C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP, Human Resources Common Stock 2014-12-04 4 M 0 937 53.74 A 35832 D Common Stock 2014-12-04 4 S 0 500 118.40 D 35332 D Common Stock 2014-12-04 4 S 0 337 119.36 D 34995 D Common Stock 2014-12-04 4 S 0 100 120.62 D 34895 D Common Stock 150 I 401(k) Stock Option (right to buy) 53.74 2014-12-04 4 M 0 937 0.00 D 2022-09-03 Common Stock 937 6563 D Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $118.40 (range $117.92 to $118.86). Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $119.36 (range $118.95 to $119.82). The option vests in 16 quarterly installments from 09/04/2012. Omar White, Attorney-In-Fact 2014-12-05